Scotia Capital’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-200,000
Closed -$4.03M 778
2016
Q2
$4.03M Buy
200,000
+140,000
+233% +$3.96M 0.08% 161
2016
Q1
$1.58M Buy
+60,000
New +$4.44M 0.03% 283
2015
Q4
Sell
-6,500
Closed -$1.16M 800
2015
Q3
$1.16M Buy
6,500
+1,500
+30% +$350K 0.03% 355
2015
Q2
$1.11M Buy
+5,000
New +$1.11M 0.02% 380

Other funds holding BHC

Scotia Capital's BHC Position: Q2 2024 in Review

Scotia Capital sold out of Bausch Health (BHC) in Q2 2024, closing a stake of 86,436 shares — an estimated $909K sold.

Scotia Capital first reported a position in BHC in Q2 2013 and held it in 33 quarters. The position peaked at $28.8M in Q1 2014. 234 funds tracked by Wall St. Rank hold BHC as of Q2 2024.

  • Scotia Capital reported no remaining Bausch Health position as of Q2 2024 after selling out during the quarter.
  • Scotia Capital sold 86,436 Bausch Health shares in Q2 2024, an estimated $909K.
  • Scotia Capital first reported a position in Bausch Health in Q2 2013 and held it in 33 quarters.
  • Scotia Capital's Bausch Health position peaked at $28.8M in Q1 2014.
  • 234 funds tracked by Wall St. Rank held Bausch Health as of Q2 2024.

Based on Scotia Capital's 13F filing for Q2 2024, filed 14 Aug 2024.